European Heart Journal Advance Access originally published online on September 25, 2006
European Heart Journal 2006 27(22):2725-2736; doi:10.1093/eurheartj/ehl193
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
EuroHeart Failure Survey II (EHFS II): a survey on hospitalized acute heart failure patients: description of population
1 Division of Cardiology, Department of Medicine, Helsinki University Central Hospital, Haartmaninkatu 4, PO Box 340, 00029 HUS, Finland
2 Department of Cardiology, A.Z Middelheim Hospital, University of Antwerp, Belgium
3 Cardiology Division, Stavanger University Hospital, Norway
4 Abt. Kardiologie u. Angiolgie, Zentrum Innere Medizin, Med. Hochschule Hannover (MHH), Germany
5 Department of Internal Medicine, University Hospital Zurich, Switzerland
6 Stiftung Institut für Herzinfarktforschung, Ludwigshafen, Germany
7 Cardiology Department, CHU Pitie Salpetriere, Paris, France
8 Department of Cardiology—Planta 1, Hospital Universitario La Paz, Madrid, Spain
9 Department of Cardiology, Military Hospital, Wroclaw, Poland
10 Divisione di Cardiologia, Policlinico san Matteo, I.R.C.C.S, Pavia, Italy
Received 30 March 2006; revised 21 June 2006; accepted 27 July 2006; online publish-ahead-of-print 25 September 2006.
* Corresponding author. Tel: +358 9 47172200; fax: +358 9 47174015. E-mail address: markku.nieminen{at}hus.fi
See page 2619 for the editorial comment on this article (doi:10.1093/eurheartj/ehl332)
Aims The objective of the EuroHeart Failure Survey II (EHFS II) was to assess patient characteristics, aetiology, treatment, and outcome of acute heart failure (AHF) in Europe in relation to the guidelines on the diagnosis and treatment of AHF published by the European Society of Cardiology.
Methods and results Patients hospitalized for AHF were recruited by 133 centres in 30 European countries. Three thousand five hundred and eighty patients were entered into the database by the end of August 2005. Mean age was 70 years, and 61% of patients were male. New-onset AHF (de novo AHF) was diagnosed in 37%, of which 42% was due to acute coronary syndromes (ACS). Clinical classification according to the guidelines divided AHF patients into (i) decompensated HF (65%), (ii) pulmonary oedema (16%), (iii) HF and hypertension (11%), (iv) cardiogenic shock (4%), and (v) right HF (3%). Coronary heart disease, hypertension, and atrial fibrillation were the most common underlying conditions. Arrhythmias, valvular dysfunction, and ACS were each present as precipitating factor in one-third of cases. Preserved left ventricular ejection fraction (
45%) was observed in 34%. Valvular disorders were common, especially mitral regurgitation (MR) which was reported on echocardiography in 80% of patients. Median length of stay was 9 days, and in-hospital mortality 6.7%. At discharge, 80% of patients were on angiotensin-converting enzyme-inhibitors or angiotensin receptor blockers, whereas 61% were taking beta-blocker medication.
Conclusion Decompensated HF is the most common clinical presentation of AHF patients. More than one-third of AHF patients do not have a previous history of HF, and new-onset HF is often caused by ACS. Preserved systolic function is found in a substantial proportion of the patients. The prevalence of valvular dysfunction is strikingly high and contributes to the clinical presentation. The EHFS II on AHF verified that the use of evidence-based HF medication was well adopted to clinical practice.
Key Words: Acute heart failure • EuroHeart Survey • Echocardiography • Demographics • Treatment
CiteULike 
Connotea 
Del.icio.us What's this?
Related articles in EHJ:
- Is acute heart failure a highly prevalent orphan disease?
- Luc W. Eurlings, James L. Januzzi, and Yigal M. Pinto
EHJ 2006 27: 2619-2620.[Extract] [FREE Full Text]
This article has been cited by other articles:
|
|
 |
|
  L. A. Allen, A. F. Hernandez, C. M. O'Connor, and G. M. Felker End points for clinical trials in acute heart failure syndromes. J. Am. Coll. Cardiol., June 16, 2009; 53(24): 2248 - 2258. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Palardy, L. W. Stevenson, G. Tasissa, M. A. Hamilton, R. C. Bourge, T. G. DiSalvo, U. Elkayam, J. A. Hill, S. C. Reimold, and for the ESCAPE Investigators Reduction in Mitral Regurgitation During Therapy Guided by Measured Filling Pressures in the ESCAPE Trial Circ Heart Fail, May 1, 2009; 2(3): 181 - 188. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. Jaarsma, J. M. Beattie, M. Ryder, F. H. Rutten, T. McDonagh, P. Mohacsi, S. A. Murray, T. Grodzicki, I. Bergh, M. Metra, et al. Palliative care in heart failure: a position statement from the palliative care workshop of the Heart Failure Association of the European Society of Cardiology Eur J Heart Fail, May 1, 2009; 11(5): 433 - 443. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Komajda How well are we implementing evidence-based care? Eur J Heart Fail Suppl, April 1, 2009; 8(suppl_1): i39 - i44. [Full Text] [PDF]
|
|
|
|
|
|
A. Mebazaa, M. S. Nieminen, G. S. Filippatos, J. G. Cleland, J. E. Salon, R. Thakkar, R. J. Padley, B. Huang, and A. Cohen-Solal Levosimendan vs. dobutamine: outcomes for acute heart failure patients on {beta}-blockers in SURVIVE Eur J Heart Fail, March 1, 2009; 11(3): 304 - 311. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. M. Hawkins, Z. Huang, K. S. Pieper, S. D. Solomon, L. Kober, E. J. Velazquez, K. Swedberg, M. A. Pfeffer, J. J.V. McMurray, A. P. Maggioni, et al. Chronic obstructive pulmonary disease is an independent predictor of death but not atherosclerotic events in patients with myocardial infarction: analysis of the Valsartan in Acute Myocardial Infarction Trial (VALIANT) Eur J Heart Fail, March 1, 2009; 11(3): 292 - 298. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. Willenheimer The current role of beta-blockers in chronic heart failure: with special emphasis on the CIBIS III trial Eur. Heart J. Suppl., March 1, 2009; 11(suppl_A): A15 - A20. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Gheorghiade and P. S. Pang Acute heart failure syndromes. J. Am. Coll. Cardiol., February 17, 2009; 53(7): 557 - 573. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Komajda, O. Hanon, M. Hochadel, J. L. Lopez-Sendon, F. Follath, P. Ponikowski, V.-P. Harjola, H. Drexler, K. Dickstein, L. Tavazzi, et al. Contemporary management of octogenarians hospitalized for heart failure in Europe: Euro Heart Failure Survey II Eur. Heart J., February 2, 2009; 30(4): 478 - 486. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. Abrahamsson, J. Dobson, C. B. Granger, J. J.V. McMurray, E. L. Michelson, M. Pfeffer, S. Pocock, S. D. Solomon, S. Yusuf, K. Swedberg, et al. Impact of hospitalization for acute coronary events on subsequent mortality in patients with chronic heart failure Eur. Heart J., February 1, 2009; 30(3): 338 - 345. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. M. Hawkins, M. C. Petrie, P. S. Jhund, G. W. Chalmers, F. G. Dunn, and J. J.V. McMurray Heart failure and chronic obstructive pulmonary disease: diagnostic pitfalls and epidemiology Eur J Heart Fail, February 1, 2009; 11(2): 130 - 139. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. D. Flaherty, J. J. Bax, L. De Luca, J. S. Rossi, C. J. Davidson, G. Filippatos, P. P. Liu, M. A. Konstam, B. Greenberg, M. R. Mehra, et al. Acute heart failure syndromes in patients with coronary artery disease early assessment and treatment. J. Am. Coll. Cardiol., January 20, 2009; 53(3): 254 - 263. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Stewart, D. Wilkinson, C. Hansen, V. Vaghela, R. Mvungi, J. McMurray, and K. Sliwa Predominance of Heart Failure in the Heart of Soweto Study Cohort: Emerging Challenges for Urban African Communities Circulation, December 2, 2008; 118(23): 2360 - 2367. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Swedberg, J. Cleland, M. R. Cowie, M. Nieminen, S. G. Priori, L. Tavazzi, D. J. van Veldhuisen, L. Alonso-Pulpon, J. Camm, K. Dickstein, et al. Successful treatment of heart failure with devices requires collaboration Eur J Heart Fail, December 1, 2008; 10(12): 1229 - 1235. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Stork, H. W. Hense, C. Zentgraf, I. Uebelacker, R. Jahns, G. Ertl, and C. E. Angermann Pharmacotherapy according to treatment guidelines is associated with lower mortality in a community-based sample of patients with chronic heart failure A prospective cohort study Eur J Heart Fail, December 1, 2008; 10(12): 1236 - 1245. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. E.A. Blair, F. Zannad, M. A. Konstam, T. Cook, B. Traver, J. C. Burnett Jr, L. Grinfeld, H. Krasa, A. P. Maggioni, C. Orlandi, et al. Continental Differences in Clinical Characteristics, Management, and Outcomes in Patients Hospitalized With Worsening Heart Failure: Results From the EVEREST (Efficacy of Vasopressin Antagonism in Heart Failure: Outcome Study with Tolvaptan) Program J. Am. Coll. Cardiol., November 11, 2008; 52(20): 1640 - 1648. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. E. Hermansen, M. Hansen, M. Roaldsen, S. Muller, O.-J. How, and T. Myrmel Utilization and outcome of coronary revascularization and valve procedures in acute heart failure - an evaluation based on the classification from the European Society of Cardiology Interactive CardioVascular and Thoracic Surgery, October 1, 2008; 7(5): 833 - 838. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Authors/Task Force Members, K. Dickstein, A. Cohen-Solal, G. Filippatos, J. J.V. McMurray, P. Ponikowski, P. A. Poole-Wilson, A. Stromberg, D. J. van Veldhuisen, D. Atar, et al. ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2008 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association of the ESC (HFA) and endorsed by the European Society of Intensive Care Medicine (ESICM) Eur. Heart J., October 1, 2008; 29(19): 2388 - 2442. [Full Text] [PDF]
|
|
|
|
|
|
K. Dickstein, A. Cohen-Solal, G. Filippatos, J. J.V. McMurray, P. Ponikowski, P. A. Poole-Wilson, A. Stromberg, D. J. van Veldhuisen, D. Atar, A. W. Hoes, et al. ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2008 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association of the ESC (HFA) and endorsed by the European Society of Intensive Care Medicine (ESICM) Eur J Heart Fail, October 1, 2008; 10(10): 933 - 989. [Full Text] [PDF]
|
|
|
|
 |
|
 A. Gray, S. Goodacre, D. E. Newby, M. Masson, F. Sampson, J. Nicholl, and the 3CPO Trialists Noninvasive Ventilation in Acute Cardiogenic Pulmonary Edema N. Engl. J. Med., July 10, 2008; 359(2): 142 - 151. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 I. Klein and S. Danzi Thyroid Hormone Treatment to Mend a Broken Heart J. Clin. Endocrinol. Metab., April 1, 2008; 93(4): 1172 - 1174. [Full Text] [PDF]
|
|
|
|
|
|
P. S. Pang, J. G.F. Cleland, J. R. Teerlink, S. P. Collins, C. J. Lindsell, G. Sopko, W. F. Peacock, G. C. Fonarow, A. Z. Aldeen, J. D. Kirk, et al. A proposal to standardize dyspnoea measurement in clinical trials of acute heart failure syndromes: the need for a uniform approach Eur. Heart J., March 2, 2008; 29(6): 816 - 824. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. S. Nieminen and V.-P. Harjola Heart failure in the elderly: How risky is it to be discharged? Eur J Heart Fail, March 1, 2008; 10(3): 222 - 223. [Full Text] [PDF]
|
|
|
|
|
|
J. A. Ezekowitz, J. A. Bakal, P. Kaul, C. M. Westerhout, and P. W. Armstrong Acute heart failure in the emergency department: Short and long-term outcomes of elderly patients with heart failure Eur J Heart Fail, March 1, 2008; 10(3): 308 - 314. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. P. Dal-Bianco, A. S. Jaffe, M. R. Bell, and J. K. Oh Cardiac Function and Brain-Type Natriuretic Peptide in First-Time Flash Pulmonary Edema Mayo Clin. Proc., March 1, 2008; 83(3): 289 - 296. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. S. Nieminen, V.-P. Harjola, M. Hochadel, H. Drexler, M. Komajda, D. Brutsaert, K. Dickstein, P. Ponikowski, L. Tavazzi, F. Follath, et al. Gender related differences in patients presenting with acute heart failure. Results from EuroHeart Failure Survey II Eur J Heart Fail, February 1, 2008; 10(2): 140 - 148. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. Cotter, M. Metra, O. Milo-Cotter, H. C. Dittrich, and M. Gheorghiade Fluid overload in acute heart failure -- Re-distribution and other mechanisms beyond fluid accumulation Eur J Heart Fail, February 1, 2008; 10(2): 165 - 169. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Metra, S. Nodari, G. Parrinello, T. Bordonali, S. Bugatti, R. Danesi, B. Fontanella, C. Lombardi, P. Milani, G. Verzura, et al. Worsening renal function in patients hospitalised for acute heart failure: Clinical implications and prognostic significance Eur J Heart Fail, February 1, 2008; 10(2): 188 - 195. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Masip Early continuous positive airway pressure in acute cardiogenic pulmonary oedema Eur. Heart J., December 1, 2007; 28(23): 2823 - 2824. [Full Text] [PDF]
|
|
|
|
|
|
A. Macchia, S. Monte, M. Romero, A. D'Ettorre, and G. Tognoni The prognostic influence of chronic obstructive pulmonary disease in patients hospitalised for chronic heart failure Eur J Heart Fail, September 1, 2007; 9(9): 942 - 948. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Metra, P. Ponikowski, K. Dickstein, J. J.V. McMurray, A. Gavazzi, C.-H. Bergh, A. G. Fraser, T. Jaarsma, A. Pitsis, P. Mohacsi, et al. Advanced chronic heart failure: A position statement from the Study Group on Advanced Heart Failure of the Heart Failure Association of the European Society of Cardiology Eur J Heart Fail, June 1, 2007; 9(6-7): 684 - 694. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Mebazaa, M. S. Nieminen, M. Packer, A. Cohen-Solal, F. X. Kleber, S. J. Pocock, R. Thakkar, R. J. Padley, P. Poder, M. Kivikko, et al. Levosimendan vs Dobutamine for Patients With Acute Decompensated Heart Failure: The SURVIVE Randomized Trial JAMA, May 2, 2007; 297(17): 1883 - 1891. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
O. M. Jolobe Lessons from EuroHeart Failure Survey Eur. Heart J., April 2, 2007; 28(8): 1037 - 1037. [Full Text] [PDF]
|
|
|
|
|
|
M. A. Konstam, M. Gheorghiade, J. C. Burnett Jr, L. Grinfeld, A. P. Maggioni, K. Swedberg, J. E. Udelson, F. Zannad, T. Cook, J. Ouyang, et al. Effects of Oral Tolvaptan in Patients Hospitalized for Worsening Heart Failure: The EVEREST Outcome Trial JAMA, March 28, 2007; 297(12): 1319 - 1331. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Gheorghiade, M. A. Konstam, J. C. Burnett Jr, L. Grinfeld, A. P. Maggioni, K. Swedberg, J. E. Udelson, F. Zannad, T. Cook, J. Ouyang, et al. Short-term Clinical Effects of Tolvaptan, an Oral Vasopressin Antagonist, in Patients Hospitalized for Heart Failure: The EVEREST Clinical Status Trials JAMA, March 28, 2007; 297(12): 1332 - 1343. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. W. Eurlings, J. L. Januzzi, and Y. M. Pinto Is acute heart failure a highly prevalent orphan disease? Eur. Heart J., November 2, 2006; 27(22): 2619 - 2620. [Full Text] [PDF]
|
|